Shared Development Costs. This Section 12.6 applies to Development Costs for Dose Range Finding Studies and GLP Tox Studies for Original Products, to Development Costs for Phase I Completed Original Products and to Development Costs for C4T Co-Dev Products.
Appears in 2 contracts
Sources: License Agreement (C4 Therapeutics, Inc.), License Agreement (C4 Therapeutics, Inc.)